Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Governments Can’t Plan Economy’s Reopening
Benjamin Powell
-
April 18, 2020
Economy Prosperity or Pandemic Protection: Why Not Both?
April 15, 2020
Cut Regulations and Get COVID-19 Drugs to Patients
April 8, 2020
Drug Is Safe and Sometimes Works, Let All COVID-19 Patients Take It
April 2, 2020
What's New
Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus
Raymond March
-
April 1, 2020
0
Trust Private Enterprise to Flatten the Curve
Raymond March
-
March 27, 2020
0
FDA Should Expand Options for Coronavirus Patients
Ross Marchand
-
March 26, 2020
0
The Mask Madness of Big Government
K. Lloyd Billingsley
-
March 26, 2020
0
To Battle Covid-19, Cut Regulation!
Raymond March
-
March 25, 2020
0
Favor Local Action to Combat the Coronavirus
Raymond March
-
March 19, 2020
0
FDA Acknowledges Coronavirus Is Causing More Drug Shortages
Raymond March
-
March 6, 2020
0
FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices
Raymond March
-
March 5, 2020
0
There’s a Wrong Way to React to a Drug Shortage—and a...
Connor Norris
-
February 28, 2020
0
Who Should Regulate Tobacco Products? Less Is More!
February 27, 2020
FDA Expands Ecstasy Access to Veterans with PTSD
February 12, 2020
Politicians Still Misunderstand High Insulin Prices
February 5, 2020
Are More Vaping Bans Coming Soon? Let’s Hope Not!
January 21, 2020
365,007
Fans
Like
1,598
Followers
Follow
30,127
Followers
Follow
37,200
Subscribers
Subscribe
Edit with Live CSS
